Enhanced Trained Immunity in Myeloid Cells by SHIP-1 Inhibition

John D Chisholm; William Kerr; David Sancho Madrid; Paula Saz Leal; Carlos Del Fresno Sanchez

Enhanced Trained Immunity in Myeloid Cells by SHIP-1 Inhibition

John D Chisholm (Inventor), William Kerr (Inventor), David Sancho Madrid (Inventor), Paula Saz Leal (Inventor), Carlos Del Fresno Sanchez (Inventor)

Research output: Patent

Abstract

The present invention refers to the medical field. Particularly, it refers to SHIP-1 inhibitors for use in enhancing the non-specific response of trained innate immune cells (i.e. enhancing the training of the innate immune cells) in a subject, wherein the SHIP-1 inhibitor is administered before, after or simultaneously to a treatment with a stimulus responsible for training the innate immune cells.

Original language	English (US)
State	Published - Dec 12 2019

Cite this

@misc{624ee04c640c41f19cdc060e2d0f7653,

title = "Enhanced Trained Immunity in Myeloid Cells by SHIP-1 Inhibition",

abstract = "The present invention refers to the medical field. Particularly, it refers to SHIP-1 inhibitors for use in enhancing the non-specific response of trained innate immune cells (i.e. enhancing the training of the innate immune cells) in a subject, wherein the SHIP-1 inhibitor is administered before, after or simultaneously to a treatment with a stimulus responsible for training the innate immune cells.",

author = "Chisholm, {John D} and William Kerr and {Sancho Madrid}, David and {Saz Leal}, Paula and {Del Fresno Sanchez}, Carlos",

year = "2019",

month = dec,

day = "12",

language = "English (US)",

type = "Patent",

}

TY - PAT

T1 - Enhanced Trained Immunity in Myeloid Cells by SHIP-1 Inhibition

AU - Chisholm, John D

AU - Kerr, William

AU - Sancho Madrid, David

AU - Saz Leal, Paula

AU - Del Fresno Sanchez, Carlos

PY - 2019/12/12

Y1 - 2019/12/12

N2 - The present invention refers to the medical field. Particularly, it refers to SHIP-1 inhibitors for use in enhancing the non-specific response of trained innate immune cells (i.e. enhancing the training of the innate immune cells) in a subject, wherein the SHIP-1 inhibitor is administered before, after or simultaneously to a treatment with a stimulus responsible for training the innate immune cells.

AB - The present invention refers to the medical field. Particularly, it refers to SHIP-1 inhibitors for use in enhancing the non-specific response of trained innate immune cells (i.e. enhancing the training of the innate immune cells) in a subject, wherein the SHIP-1 inhibitor is administered before, after or simultaneously to a treatment with a stimulus responsible for training the innate immune cells.

M3 - Patent

ER -

Enhanced Trained Immunity in Myeloid Cells by SHIP-1 Inhibition

Abstract

Fingerprint

Cite this